Journal
CLEVELAND CLINIC JOURNAL OF MEDICINE
Volume 84, Issue 8, Pages 631-638Publisher
CLEVELAND CLINIC
DOI: 10.3949/ccjm.84a.16033
Keywords
-
Categories
Ask authors/readers for more resources
Combined hormonal contraceptives are contraindicated in women who have migraine with aura, in whom these drugs can increase the risk of ischemic stroke. However, this contraindication is based on data from the 1960s and 1970s, when oral contraceptives contained much higher doses of estrogen. Stroke risk is not significantly increased with today's preparations, many of which contain less than 30 mu g of ethinyl estradiol. Further, in continuous regimens, ultra-low-dose formulations-those that contain less than 20 mu g of ethinyl estradiol-may help prevent menstrual migraine and reduce the frequency of aura.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available